Junbaiyan Holdings (08372) released its annual results ending on March 31, 2024, with revenue of HKD 81.903 million, a YoY growth of 6.78%; shareholders have earned HKD 7.855 million in net profit, a YoY growth of 3.87%; earnings per share is 0.98 HK cents, and the proposed interim dividend for ordinary shares is 0.25 HK cents per share.

It is reported that the increase in revenue is mainly due to the lifting of COVID-19 restrictions, allowing the economy to recover and increasing revenue generated from medical devices.